Clinical Trial Update: Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of three cycles of fludarabine followed by tositumomab and iodine-131 tositumomab in Non-Hodgkin lymphoma. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Fludarabine (Fludarabine)
• Iodine-131-tositumomab (Iodine-131-tositumomab)
• Tositumomab (tositumomab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2012-03-13